Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy

Molecular Biology Reports

Volumn 39, Issue 9, 2012, Pages 8669-8678

  Kasznicki, Jacek ^a   Kosmalski, Marcin ^a   Sliwinska, Agnieszka ^a   Mrowicka, Malgorzata ^a   Stanczyk, Malgorzata ^a   Majsterek, Ireneusz ^a   Drzewoski, Jozef ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Activity of antioxidant enzymes; Antioxidant status; Diabetic neuropathy; Nitric oxide; Oxidative DNA damage; Oxidative stress

Indexed keywords

CATALASE; ENDONUCLEASE; ENDONUCLEASE III; GLICOSYLOFORMAMIDOGLICOSYLASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; NITROUS OXIDE; OXIDOREDUCTASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL ISOLATION; COMET ASSAY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETOGENESIS; DISTAL SYMMETRIC POLYNEUROPATHY; DNA DAMAGE; ENZYME ACTIVITY; FEMALE; HEALTH STATUS; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BIOLOGICAL MARKERS; DIABETIC NEUROPATHIES; DNA DAMAGE; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 84865110431     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1722-9     Document Type: Article

References (63)

1. Boulton AJM, Vinik AI, Arezzo JC, Feldman EI, Freeman R, Malik RA, Mase RE, Sosenko JM, Ziegler D (2005) Diabetic neuropathies. Diabetes Care 28:956-962 (Pubitemid 40434506)
2. Boulton AJM (2005) Management of diabetic neuropathy. Clin Diabetes 23:9-15 (Pubitemid 40973398)
3. The DCCT Research Group (1988) Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of diabetes control and complications trial (DCCT). Diabetes 37:476-481
4. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC (1997) Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 49:229-239 (Pubitemid 27328707)
5. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ, O'Brien PC (1999) Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 22:1479-1486 (Pubitemid 29418242)
6. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA, Service FJ, Rizza AM, Zimmerman BR (1991) The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 41:799-807
7. Tesfaye S, Boulton AJM, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P, on behalf of the Toronto Diabetic Neuropathy Expert Group (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285-2293
8. Bloomgarden ZT (2007) Diabetic neuropathy. Diabetes Care 30:1027-1032 (Pubitemid 46556606)
9. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, Cohen JA, Fisher MA, Howard JF, Kinsella LJ, Latov N, Lewis RA, Low PA, Sumner AJ (2005) Distal symmetric polyneuropathy: a definition for clinical research. Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 64:199-207
10. Vinik AI, Mitchell BD, Maser RE, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553-1579 (Pubitemid 36934465)
11. Coppini DV, Bowtell PA, Weng C, Young PJ, Sonksen PH (2000) Showing neuropathy is related to increased mortality in diabetic patients-a survival analysis using an accelerated failure time model. J Clin Epidemiol 53:519-523 (Pubitemid 30254349)
12. Argoff CE, Cole BE, Fishbain DA, Irving GA (2006) Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc 81(4 Suppl):S3-S11
13. Ceriello A (2003) New insights on oxidative stress and diabetic complications may lead to "casual" antioxidant therapy. Diabetes Care 26:1589-1596 (Pubitemid 36929196)
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus (2003) Diabetes Care 26 (Suppl. 1): S5-S20
15. Rader AJ, Barry TP, Stanley OL (2008) Characteristics of lower extremity pressure sensation impairment in developing diabetic sensory polyneuropathy. Foot Ankle Spec 21:39-45
16. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281-1289 (Pubitemid 24324972)
17. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH, Torkington R, van Ross ER, Whalley AM, Widdows P, Williamson S, Boulton AJ (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19:377-384 (Pubitemid 34534212)
18. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM (2004) Diabetic somatic neuropathies. Diabetes Care 27:1458-1486 (Pubitemid 38680000)
19. Hilz MJ, Axelrod FB, Hermann K, Haertl U, Duetsch M, Neundörfer B (1998) Normative values of vibratory perception in 530 children, juveniles and adults aged 3-79 years. J Neurol Sci 159:219-225 (Pubitemid 28384533)
20. Meijer J-WG, Smit AJ, Lefrandt JD, van der Hoeven JH, Hoogenberg K, Links TP (2005) Back to basics in diagnosing diabetic polyneuropathy with tuning fork. Diabetes Care 28:2201-2205 (Pubitemid 41242468)
21. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, Landsman AS, Lavery LA, Moore JC, Schuberth JM, Wukich DK, Andersen C, Vanore JV (2006) Diabetic foot disorders: a clinical practice guideline (2006 revision). J Foot Ankle Surg 45(Suppl):S1-S66 (Pubitemid 46187108)
22. Van Kampen E, Zijlstra WG (1961) Standardization of hemoglobinometry. II. The hemiglobincyanide method. Clin Chim Acta 6:538-544
23. Misra HP, Ridovich J (1972) The role superoxide anion in the autooxidation of epinephrine and a simple assay for the superoxide dismutases. J Biol Chem 247:3170-3175
24. Singh NP, McCoy T, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-192
25. Klaude M, Eriksson S, Nygren J, Ahnstrom G (1996) The comet assay: mechanisms and technical considerations. Mutat Res 363:89-96 (Pubitemid 26225011)
26. Collins AR, Duthie SJ, Dobson VL (1993) Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 14:1733-1735 (Pubitemid 23290881)
27. David-Cordonnier MH, Laval J, O'Neill P (2000) Clustered DNA damage, influence on damage excision by XRS5 nuclear extracts and Escherichia coli Nth and Fpg proteins. J Biol Chem 275:11865-11873 (Pubitemid 30237755)
28. Boiteux S, Gajewski E, Laval J, Dizdaroglu M (1992) Substrate specificity of the Escherichia coli Fpg protein (formamidopyrimidine-DNA glycosylase): excision of purine lesions in DNA produced by ionizing radiation or photosensitization. Biochemistry 31:106-110
29. Tchou J, Kasai H, Shibutani S, Chung MH, Laval J, Grollman AP, Nishimura S (1991) 8-oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc Natl Acad Sci USA 88:4690-4694 (Pubitemid 21914607)
30. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625 (Pubitemid 40770750)
31. Al-Nimer MS, Al-Ani FS, Ali FS (2012) Role of nitrosative and oxidative stress in neuropathy in patients with type 2 diabetes mellitus. J Neurosci Rural Pract 3:41-44
32. Obrosova IG (2002) How does glucose generate oxidative stress in peripheral nerve? Int Rev Neurobiol 50:3-35
33. Bjorkman JA, Sutherland J, Gusttafson D (1991) Superoxide dismutase and catalase do not improve recovery of regional myocardial contractile function when given at the time of reperfusion after reversible regional ischemia in anesthetized dogs. Basic Res Cardiol 86:236-244
34. Buczyński A, Wachowicz B, Kedziora-Kornatowska K (1993) Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 100:223-228 (Pubitemid 23183721)
35. Beers R, Sizer T (1952) Spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:133-140
36. Little C, O'Brian P (1968) Intracellular GSH-peroxidase with a lipid peroxide substrate. Biophys Res Commun 31:145-150
37. El Boghdady NA, Bard GA (2012) Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathy. Cell Biochem Funct 30(4):328-334. doi: doi: 10.1002/cbf.2808
38. Brodsky SV, Morrishow AM, Dharia N, Gross SS, Goligorsky MS (2001) Glucose scavenging of nitric oxide. Am J Physiol Renal Physiol 280:F480-F486
39. Srinivasan S, Hatley ME, Bolick DT, Palmer LA, Edelstein D, Brownlee M, Hedrick CC (2004) Hyperglycemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 47:1727-1734 (Pubitemid 40022408)
40. Ozkul A, Ayhan M, Yenisey C, Akyol A, Guney E, Ergin FA (2010) The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain. Neuro Endocrinol Lett 31:261-264
41. Ramakrishna V, Jailkhani R (2008) Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 45:41-46 (Pubitemid 351238275)
42. Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer A (2001) Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin Biochem 34:65-70 (Pubitemid 32178508)
43. Drzewoski J (2008) Gliclazide, inflammation and atherosclerosis. Antiinflamm Antiallergy Agents Med Chem 7:224-230
44. Bonnefont-Rousselot D (2002) Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 5:561-568 (Pubitemid 40684653)
45. Pan HZ, Zhang H, Chang D, Li H, Sui H (2008) The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92:548-551 (Pubitemid 351497989)
46. Bolajoko EB, Mossanda KS, Adeniyi F, Akinosun O, Fasanmade A, Moropane M (2008) Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer. S Afr Med J 98:614-617
47. Adaikalakoteswari A, Rema M, Mohan V, Balasubramanyam M (2007) Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy. Int J Biochem Cell Biol 39:1673-1684 (Pubitemid 47088311)
48. Sliwinska A, Blasiak J, Kasznicki J, Drzewoski J (2008) In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM). Chem Biol Interact 173:159-165
49. Pitozzi V, Giovannelli L, Bardini G, Rotella CM, Dolara P (2003) Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: higher vulnerability of polymorphonuclear leukocytes. Mutat Res 529:129-133 (Pubitemid 37013395)
50. Piwowar A, Knapik-Kordecka M, Warwas M (2007) AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus. Diabetes Res Clin Pract 77:188-192 (Pubitemid 46670416)
51. Tiedge M, Lortz S, Drinkgern J, Lenzen S (1997) Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46:1733-1742 (Pubitemid 27456404)
52. Merzouk S, Hichami A, Madani S, Merzouk H, Berouiguet AY, Prost J, Moutariou K, Chabane-Sari N, Khan NA (2003) Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications. Gen Physiol Biophys 22:15-27 (Pubitemid 36748377)
53. Lodovici M, Giovannelli L, Pitozzi V, Bigagli E, Bardini G, Rotella CM (2008) Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutat Res 638:98-102
54. Demirbag R, Yilmaz R, Kocyigi A (2005) Relationship between DNA damage, total antioxidant capacity and coronary artery disease. Mutat Res 570:197-203 (Pubitemid 40222270)
55. Faure P, Wiernsperger N, Polge C, Favier A, Halimi S (2008) Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin. Clin Sci (Lond) 114:251-256 (Pubitemid 351294000)
56. Atli T, Keven K, Avci A, Kutlay S, Turkcapar N, Varli M, Aras S, Ertug E, Canbolat O (2004) Oxidative stress and antioxidant status in elderly diabetes mellitus and glucose intolerance patients. Arch Gerontol Geriatr 39:269-275 (Pubitemid 39277486)
57. Ceriello A, Bortolotti N, Crescentini A, Motz E, Lizzio S, Russo A, Ezsol Z, Tonutti L, Taboga C (1998) Antioxidant defenses are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. Eur J Clin Invest 28:329-333 (Pubitemid 28188309)
58. Hovnik T, Dolzan V, Ursic Bratina N, Trebusak Podkrajsek K, Battelino T (2009) Genetic polymorphisms in genes encoding antioxidant enzymes are associated with diabetic retinopathy in type 1 diabetes. Diabetes Care 32:2258-2262
59. Lin TL, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787-795 (Pubitemid 44622683)
60. Szaflik JP, Majsterek I, Kowalski M, Rusin P, Sobczuk A, Borucka AI, Szaflik J, Blasiak J (2008) Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy. Exp Eye Res 86:647-652
61. Majsterek I, Malinowska K, Stanczyk M, Kowalski M, Blaszczyk J, Kurowska AK, Kaminska A, Szaflik J, Szaflik JP (2011) Evaluation of oxidative stress markers in pathogenesis of primary open-angle glaucoma. Exp Mol Pathol 90:231-237
62. Szaflik JP, Rusin P, Zaleska-Zmijewska A, Kowalski M, Majsterek I, Szaflik J (2010) Reactive oxygen species promote localized DNA damage in glaucoma-iris tissues of elderly patients vulnerable to diabetic injury. Mutat Res 697:19-23
63. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L (2001) The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17:189-212 (Pubitemid 32624602)